Berberis Aristata

Berberis aristata  DC.

1. Taxonomic, Nomenclature & Therapeutic Summary Table

Botanical Attribute Pharmacognostic & Therapeutic Specification
Subspecies B. asiatica Roxb. ex DC.
Substitute B. lycium Royle & other species.
Family Berberidaceae.
Habitat Northwestern Himalayas, Nilgiris, Kulu and Kumaon.
English Indian Barberry.
Ayurvedic Daaruharidraa, Daaru, Daarvi, Daarunishaa, Daarurajani, Vrahitaphala, Valliphala, Sthirphala. Pushpaphala, Somakaa, Parjanyaa, Parjani, Kantkateri, Taarthya, Pachampachaa. Kaaliyaka is now equated with Pita Chandana (Coscinium fenestratum (Gaertn.) Colebr., Menispermaceae). Extract—Rasaanjana.
Unani Daarhald. Rasaut (extract). Zarishk (fruit).
Siddha / Tamil Marmanjal.
Action Rasaut, Rasasranjana (extract)—bitter, cholagogue, antidiarrhoeal, stomachic, laxative, diaphoretic, antipyretic, antiseptic. Used externally in opthalmia,conjunctivitis, ulcers, sores, swollen gums. Root bark— anti-inflammatory, hypoglycaemic hypotensive, antiamoebic, anticoagulant, antibacterial. Bark— used in liver complaints, diarrhoea, dysentery, cholera, gastric disorders, enlargement of spleen and for regulating metabolism. Berries— antiscorbutic, laxative.
Dosage Extract—1–3 g (CCRAS.); dried stem—5–10 ml decoction. (API Vol. II.)
Taxonomic Cohort Genus Berberis (3 documented species); Family Berberidaceae (6 documented species).

2. Classical Nomenclature, Taxonomy & Biogeographical Context

Berberis aristata (taxonomically cited with authority DC.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Berberidaceae (primary family classification: Berberidaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: Northwestern Himalayas, Nilgiris, Kulu and Kumaon.

Across classical and vernacular Indian systems of medicine, Berberis aristata is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Indian Barberry; in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Daaruharidraa, Daaru, Daarvi, Daarunishaa, Daarurajani, Vrahitaphala, Valliphala, Sthirphala. Pushpaphala, Somakaa, Parjanyaa, Parjani, Kantkateri, Taarthya, Pachampachaa. Kaaliyaka is now equated with Pita Chandana (Coscinium fenestratum (Gaertn.) Colebr., Menispermaceae). Extract—Rasaanjana; in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Daarhald. Rasaut (extract). Zarishk (fruit); in the Siddha and Tamil medical tradition (compiled from the Formulary of Siddha Medicine and IMPCOPS Chennai) as Marmanjal. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.

3. Therapeutic Actions, Phytochemistry & Pharmacological Profile

In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Berberis aristata are: Rasaut, Rasasranjana (extract)—bitter, cholagogue, antidiarrhoeal, stomachic, laxative, diaphoretic, antipyretic, antiseptic. Used externally in opthalmia,conjunctivitis, ulcers, sores, swollen gums. Root bark— anti-inflammatory, hypoglycaemic hypotensive, antiamoebic, anticoagulant, antibacterial. Bark— used in liver complaints, diarrhoea, dysentery, cholera, gastric disorders, enlargement of spleen and for regulating metabolism. Berries— antiscorbutic, laxative. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.

Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Berberis aristata establish the following evidence base: Berberine hydrochloride and sulphate help in the diagnosis of latent malaria by releasing the parasites into the blood stream. Alkaloid berberine possesses antibacterial and anti-inflammatory activities. It is used as an intestinal antiseptic and bitter stomachic. It also exhibits antineoplastic properties. (Its synthetic derivative dihydroberberine is used in brain tumour.) Berberine has been found to inhibit the activity of enzymes trypsin (32%) and chymotrypsin (60%) in in-vitro studies. B. asiatica Roxb.ex Dc. is found in the Himalaya at 900–3,000 m, Assam and Bihar. See B. vulgaris.

In specialized pharmacognostic classifications, Berberis aristata is also recognized among important classical herbs with divergent regional plant sources across North and South Indian formularies; and listed among standardized commercial herbal extracts used in India with defined quantitative phytochemical markers; and represented by authenticated macro-photographic crude drug specimens in institutional pharmacognostic collections.

image1

Figure 1: Authenticated crude herb specimen — Berberis aristata stem bark.

image3

Botanical Reference 1: Berberis aristata — Botanical specimen

image4

Botanical Reference 2: Berberis aristata — Botanical specimen

image4

Botanical Reference 3: Berberis aristata — Wikimedia Commons reference

4. Comparative Genus & Family Pharmacognosy

Taxonomically, the genus Berberis comprises 3 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Berberis chitria (Action: Same as that of Berberis aristata); Berberis vulgaris (Action: Root and bark—used for ailments of gastrointestinal tract, liver, gallbladder…). Comparing Berberis aristata alongside its congeners in genus Berberis highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.

At the family level, Berberidaceae encompasses 6 documented medicinal species (0.33% of the 1,814-species flora). Other representative medicinal members of Berberidaceae include: Berberis chitria (Daaruharidraa), Berberis vulgaris (Daruharidraa), Mahonia napalensis (Holly Leaved Berberry), Podophyllum hexandrum (Giriparpata). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

image2

Figure 2: Quantitative documentation profile across all 6 medicinal species of family Berberidaceae.

5. Pharmacopoeial Standards, Posology & Reference Framework

For clinical and traditional dispensing, the standardized posology and crude herb dosage for Berberis aristata are prescribed as follows: Extract—1–3 g (CCRAS.); dried stem—5–10 ml decoction. (API Vol. II.). Crude drug dosages are calibrated against The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and the Standard Nomenclature of Ayurvedic Medicinal Plants published by the Central Council for Research in Ayurveda and Siddha (CCRAS). Classical and modern pharmacognostic synchronization for Berberis aristata integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.

Scroll to Top